The September 2017 amendments to the Patented Medicines (Notice of Compliance) Regulations introduced a new scheme for pharmaceutical patent linkage litigation in Canada. That scheme is now much closer to the United States' (US) Hatch-Waxman scheme, but with remaining key differences that are explained in this chart.
In this Sample Trade Secret Policy, in-house counsel can review informative language about trade secrets and how to define them for potential new employees in the United States.
In this Sample Acknowledgement Form, an incoming employee is reviewing and acknowledging the trade secrets policy the hiring company has instituted.
In this example of possible "Notice" language about Whistleblower Immunity, language is constructed to inform a possible whistleblower of their rights and immunity.
In this Sample Exit Interview Form, a United States Company is categorizing access to tools and information from the former employee.
This ACC Guide provides an overview on trade secrets in the United States. It will explain the legal framework that in-house counsel can use to inform, protect, and provide guidance when dealing with trade secrets, intellectual property usage, and what you company might face in attempting to protect certain information.
When you take your year in stock, it feels like it's time answer some fundamental questions about your life, career, relationships and finances. How long should I continue to work? What things should I be thinking about for my “post” career years and what is my professional legacy? These questions should not wait to be answered. Take control of your gray years and turn them into great years.
When do you need acquired business financial disclosures in a prospectus under the SEC's amended rules?